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Abstract Prediction of the bound configuration of small-
molecule ligands that differ substantially from the cognate
ligand of a protein co-crystal structure is much more
challenging than re-docking the cognate ligand. Success
rates for cross-docking in the range of 20–30 % are com-
mon. We present an approach that uses structural infor-
mation known prior to a particular cutoff-date to make
predictions on ligands whose bounds structures were de-
termined later. The knowledge-guided docking protocol
was tested on a set of ten protein targets using a total of 949
ligands. The benchmark data set, called PINC (‘‘PINC Is
Not Cognate’’), is publicly available. Protein pocket simi-
larity was used to choose representative structures for
ensemble-docking. The docking protocol made use of
known ligand poses prior to the cutoff-date, both to help
guide the configurational search and to adjust the rank of
predicted poses. Overall, the top-scoring pose family was
correct over 60 % of the time, with the top-two pose
families approaching a 75 % success rate. Correct poses
among all those predicted were identified nearly 90 % of
the time. The largest improvements came from the use of
molecular similarity to improve ligand pose rankings and
the strategy for identifying representative protein struc-
tures. With the exception of a single outlier target, the
knowledge-guided docking protocol produced results
matching the quality of cognate-ligand re-docking, but it
did so on a very challenging temporally-segregated cross-
docking benchmark.
Keywords Docking  Protein flexibility  Surflex 
Molecular similarity  Data fusion  Pose prediction
Introduction
Docking of small molecules to protein binding sites by
computational means is now a mature field, having been
established on rigid ligands in the 1980s [1]. The first
practical methods that addressed ligand flexibility in an
automatic fashion appeared in the 1990s, with AutoDock
[2], GOLD [3, 4], Hammerhead [5–7], and FlexX [8, 9].
These early reports shared a common validation strategy:
re-docking of ligands into their cognate protein binding
pockets, with success rates typically defined as symmetry-
corrected RMSD B2.0 A˚. On benchmark sets containing
dozens of diverse targets, success rates in the late 1990s to
early 2000s for top-scoring pose prediction were roughly
70–80 % [4, 10, 11]. Success rates at this level for cognate
ligand re-docking have persisted across different data sets
[4, 12], though lower success rates (closer to 60 %) have
been reported for particularly challenging cognate-docking
benchmarks [13, 14]. Assessment of cognate re-docking
has continued, with a recent ACS symposium showcasing
results for eight methods [15–22]. Among the more widely
used methods (DOCK, FlexX, Glide, GOLD, and Surflex-
Dock), using agnostic procedures for complex preparation
that favored no method in particular, success rates in the
low to mid 70 % range were typical.
Multiple groups showed that nominal success rates
could be improved by ten to 20 % points through ma-
nipulation of the starting conditions for proteins and
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ligands. This is an inherent problem in this type of exercise
because the construction of the problem embeds the correct
answer, and knowledge of that answer can be used to bias
results. The risks of employing such techniques in
methodological validation [11] have been documented
previously [23, 24].
Real-world practitioners of docking face entirely dif-
ferent problems, typically involving prediction of the
binding modes of ligands during a design process, under-
standing the binding mode of a newly reported chemical
series, or identification of new lead compounds through
virtual screening. Binding-mode prediction is the focus of
this study, and it can be important for visual modeling in
compound design or as an adjunct to affinity prediction
approaches, both simulation-based [25] and those that
employ machine-learning [26, 27]. It is important to note
that while the prediction of changes in binding affinity that
result from minor changes to a ligand is a challenging and
important problem, binding modes are not often drastically
altered in such cases. So, the challenge for docking is
where a more significant structural change in a ligand is
made than from a methyl to an ethyl substituent. In such
cases, where novel ligands are to be docked (commonly
called the ‘‘cross-docking’’ problem), protocols that par-
allel those used for cognate docking perform poorly.
Three particularly influential studies of the cross-dock-
ing problem were published in the 2006–2008 time-frame.
Warren et al. [28] made an independent study of several
docking programs, both for non-cognate pose prediction
and for screening enrichment. The pose prediction aspect
involved seven targets (averaging roughly 180 ligands per
target), making use of a single protein structure as a rep-
resentative for each target. In this study, an expert choice
was made with respect to protein structure, and expert users
for each docking program were used. Performance was
highly target dependent, with average success rates across
the seven targets among the better performing methods
ranging from 20 to 35 % (but with standard deviations of
roughly the same magnitude). However, performance was
also highly method dependent. While any single method
yielded relatively poor overall performance, for four of the
seven targets, at least one of the docking methods yielded
top-scoring pose prediction success rates of at least 50 %.
Sutherland et al. [29] explored all-by-all cross-docking
using a set of 249 ligands spanning eight targets using two
docking algorithms. They performed exhaustive cross-
docking (each ligand against every non-native structure),
observing success rates ranging from 18 to 24 %. In con-
trast to the results reported by Warren et al., only in the
case of one target and one docking algorithm was the
success rate over 50 %. Verdonk et al. [30] took a different
approach, considering a highly curated set of 85 protein
ligand complexes (the ‘‘Astex Diverse Set’’) and then
asking how docking performance was affected by consid-
ering alternative protein conformations for the same set of
ligands. For this test, only the issue of protein conformation
was addressed, with the protonation and tautomeric states
being defined in the same manner as was done optimally
for the cognate protein-ligand complex. In this case, the
decrease in performance attributed to protein conformation
variation was about 20 % points (from 80 to 61 %).
The latter two studies also considered the effects of
using multiple protein variants for docking, each reporting
improvements when effective selection strategies were
adopted. Both observed that selection of structures as the
targets for docking whose cognate ligand was similar to the
non-cognate test ligand improved performance. Our own
work [31], which made use of the challenging Sutherland
data set, showed that agnostic selection of five protein
structures improved overall cross-docking performance by
roughly 20 % points over using a single-structure per target
(from 26 to 45 % considering top-scoring poses without
protein pocket optimization).
The more recent CSAR 2011–2012 Benchmark Exercise
[32] largely confirmed the success rates observed in these
previous studies for single-structure cross-docking. Multi-
ple groups, using a diversity of docking methods, submitted
pose predictions for four targets, where each was repre-
sented by a carefully chosen single protein structure. The
ligand sets consisted of congeneric series: LpxC (3 test
ligands), Urokinase (16 ligands, 1 series), Chk1 (38, 3
series), and Erk2 (39, 3 series). Percent correct over all
tested docking methods at the 2.0 A˚ threshold for the two
targets with multiple series was 28 % for Chk1 and 16 %
for Erk2. For LpxC (with just 3 ligands), 75 % correct was
reported, and for Urokinase the result was 57 %. Overall,
for all methods against all targets, the likelihood of ob-
taining a correct pose as top-ranked was 29 %.
One aspect of the cross-docking problem that offers
some reason for optimism is that the success rates for
identification of a correct pose among all those produced
by a particular method are much higher than those for the
top-scoring pose [28, 29, 31, 32]. That is, the detailed
ranking among a set of poses is often the point of failure, as
opposed to a total failure to identify any reasonable
solutions.
Clearly, the cross-docking problem is much more chal-
lenging than the cognate-docking assessments utilized
during the infancy of the field. It has been clearly estab-
lished that protein conformational variation plays an im-
portant role. Other aspects of binding site complementarity
involving protonation or tautomerism also matter, but they
have not been as carefully studied. Often discussed, but
also not systematically studied, is the fact that an expert in
a particular target system who has great facility with a
particular docking method, can often obtain results that are
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far better than those obtained from naive naı¨ve tool ap-
plication to the same system. This appears to stem from
knowledge of the target system (e.g. common variant
configurations of a binding pocket), ways in which ligands
tend to bind (e.g. particular recognition motifs that are
relatively invariant), and the ability to guide a docking
algorithm based on such knowledge.
Figure 1 shows a snapshot in time of what was known
about CDK2 inhibition using X-ray crystallography as of
June, 2003. These represent the earliest one-quarter of
CDK2 structures with active-site ligands that were de-
posited in the PDB as of Fall 2012. One can see the
characteristic, and largely invariant, hinge binding motif of
the ligands (red arrows). Faced with a question about
binding mode, a new ligand may look little like those that
have been studied experimentally. Choices must be made
about which protein structures to use, how they should be
prepared, how the binding site should be scoped and de-
fined, and how (if at all) to make use of knowledge of other
ligands’ binding modes to either guide or constrain the
docking process. Fewer than half of the ligands whose
bound structures were deposited in the PDB after those
shown in Fig. 1 had significant 2D similarity to the initial
set of 42 early CDK2 structures. Given that there was in-
terest in experimental structure determination for the li-
gands bound to CDK2, it is reasonable to expect that, in
many cases, there was uncertainty about the mode of
binding, interaction with the protein, and whether sig-
nificant conformational changes in the protein pocket were
induced.
We believe that the most relevant and challenging
question one can ask about binding mode prediction is
whether one can, given information available at a particular
time, make accurate predictions on ligands whose bound
structure was determined in the future. Figure 2 illustrates
this conceptualization of the cross-docking problem. For
CDK2, the structural information includes 42 protein-li-
gand complexes for use in making predictions on 127 that
were determined later in time. By constructing the task
through temporal partitioning and by making use of public
PDB structural data, the challenge is more difficult and
realistic in two critical ways. First, the structural diversity
Fig. 1 The structural
information available about
CDK2 inhibitors prior to July
2003: all 42 protein structures
shown with five small ligands in
the active site (top); all 42
ligands oriented with their
hinge-binding moieties upward
(bottom left); and all 42 ligands
with the viewpoint from the
kinase hinge (bottom right)
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seen in the test ligands compared with the knowns is high,
because it is rare to see effort invested in determining a
bound structure for a simple analog of another ligand
whose bound structure was known long ago. The structural
diversity among the test ligands is also high (for the same
reason, with the exception of multiple structures from
single studies). Second, restricting information to that
available prior to a particular time removes a primary
source of positive bias in modeling studies. The prediction
task is not contaminated by knowledge that was gained by
knowing the answer for the prediction at hand.
Methodologically, we describe and evaluate three new
techniques (all procedures will be described in more detail
in the ‘‘Methods, data, and computational protocols’’
section):
1. Automatic protein structure selection Given a collec-
tion of protein structures, there will be redundancy
among many variants, and there will also be outliers.
In order to perform well with respect to docking new
ligands, structures must be chosen to be representative
of the important variants in the collection. The
procedure we have adopted computes all pairwise
distances between structures based on protein binding
pocket similarity [33, 34]. Given these data, choosing a
specified number K is accomplished using K-means
clustering, with the exemplars for each cluster being
those that, on average, are closest to all cluster
members (essentially the cluster centers). A mutual
alignment is constructed using single-linkage hierar-



















































































Fig. 2 Temporal partitioning for cross-docking prediction: the information above the dotted line became publicly available prior to 6-27-2003
and is to be used to make predictions on ligands whose bound configurations was determined later
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alignment tree along with the five chosen variants for
CDK2.
2. Dynamic use of known bound ligands to guide
molecular alignment In Fig. 2, the core scaffold (2-
anilino-pyrimidine) of the new ligand can, for exam-
ple, be found in the known 1H1S ligand (an anilino-
purine). In this case, the common substructural frag-
ment offers an excellent guide as to the correct primary
alignment of the test ligand. Non-exhaustive dynamic
substructural matching of a test ligand to the full set of
previously known bound ligands is done in order to
identify well-positioned fragments. These fragments
are used to provide additional search focus on binding
motifs that are supported by experimental evidence.
3. Fusion of molecular similarity with docking scores to
improve pose family ranking The experimentally
determined configuration of the 2XNB ligand (tan
sticks, lower left of Fig. 2) manifests a core hinge-
binding interaction common among many early CDK2
inhibitors. Clues as to the likely positions and orien-
tations of the pendant groups may be found among
these inhibitors as well (e.g. favorable positions for
cations to make salt-bridges). In this work, the 3D
similarity is computed for each predicted ligand pose
from docking to the set of those previously known.
These similarity values are re-cast as probabilities, and
the natural relationship between probabilities and
energies is exploited in order to provide a correction
to the energetic score for each pose. Using the new
scores, pose families are generated. In this example,
the cluster of predicted poses covers the one derived
from experiment, with the closest individual pose
being 0.5 A˚ RMSD.
These new methods for addressing the cross-docking prob-
lem are implemented within Surflex-Dock, but the concepts
are general and should be of broad utility. We present results
on a newly curated cross-docking benchmark, which we
believe to be the largest and most relevant that is publicly
available. There are 949 test ligands, spread across ten ex-
tensively studied pharmaceutically relevant targets (ordered
from most to least test ligands): carbonic anhydrase II (CA-
II), cyclin-dependent kinase 2 (CDK2), HIV protease (HIV-
PR), thrombin, beta secretase 1 (BACE1), HSP90a, map
kinase 14 (MAPK14), PPARc, protein tyrosine phosphatase
1b (PTP1b), and the non-nucleoside site of HIV reverse
transcriptase (HIV-RT). At the time of curation in Fall 2012,
these were among the most heavily represented targets
within the PDB in terms of non-covalently bound ligands,
with the particular selections made to avoid redundancy or
lack of pharmaceutical relevance. For each target, all vari-
ants were identified by UniProt annotation, and partitioning
was done based on PDB deposition date, with the earliest
25 % of structures forming the known set from which all
predictionswould bemade and the subsequent 75 % forming
the test ligands. The benchmark data set is called PINC
(‘‘PINC Is Not Cognate’’). See www.jainlab.org for details
on PINC availability.
By combining these new techniques with our previously
established multi-structure docking protocol, we achieved a
mean success rate for top-scoring pose families of over
60 %, with the three most challenging targets from our
previous study (CDK2, MAPK14, and thrombin [31])
yielding mean performance of 71 %. Considering the top
two pose families, the overall success rate was 74 % (80 %
for the aformentioned trio). Among all pose families re-
turned, the success rates were, respectively, 88 and 90 %.
In this study, the most challenging targets were HIV-PR,
PTP1b, and PPARc. These shared in common the highest
proportion of test ligands whose structures were not only
very different by 2D similarity to previously known li-
gands, but they were also very different in terms of 3D
similarity (in their experimentally determined bound poses)
to previous ligands. Other aspects such as ligand flexibility
and binding site volume were less important.
These results are comparable to the best results obtained
in difficult cognate docking benchmarks [13, 14, 23], though
they are not quite as good as the best results obtained on the
Astex Diverse Set [12, 15], a carefully curated ‘‘clean’’
cognate benchmark upon which many methods exhibit high
performance. In a practical sense though, for targets where
there is significant knowledge to be exploited, the methods
presented here offer an automated means to deliver robust
performance in a wide variety of cases, with expectations of
the correct binding mode being among the top 2 predicted
pose families over 70 % of the time, among the top 5 over
80 % of the time, and being among all those predicted 90 %
of the time. For an automatic approach, not requiring a hu-
man expert, this represents a significant improvement in
binding mode prediction.
In a more general sense, the new techniques presented
here should be applicable beyond the particular imple-
mentation described. We believe that hybrid approaches
that combine information from docking and scoring, ligand
similarity, and protein pocket similarity will frequently
show synergistic performance improvements for lead dis-
covery and for predictions of binding mode, affinity, and
off-target biological effects.
Methods, data, and computational protocols
The results of this study are derived from a new benchmark
data set for cross-docking, which will be described in detail
first. Three new methods for making effective use of
structural information, about both proteins and ligands, will
J Comput Aided Mol Des (2015) 29:485–509 489
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be described next. Readers may find the details of the
computational protocols for data set preparation, docking,
and evaluation (that end this section) of more interest after
having read the Results and Discussion.
Structural data: the PINC benchmark
A query of the Protein Data Bank [35] on 8-1-2012,
seeking X-ray protein structures containing bound ligands,
produced an initial set of complexes. These were filtered to
retain ligands that were non-covalently bound, contained
only atoms including [H C N O S P F Cl Br I], and had
molecular weight less than 1000. Ligands were rejected
that lacked at least three heavy atoms whose minimal
distance (van der Waals surface-to-surface) with the pro-
tein was less than 1.0 A˚. Further, the relationship of the
ligands to the sites was assessed to eliminate ligands just
grazing a protein’s surface, a notion of ‘‘buried-ness’’ de-
scribed in Spitzer et al. [34], which assesses a ratio of the
number of nearby protein atoms relative to the total number
of ligand heavy atoms. The filtering criteria were designed
in order to preserve all of the ligand binding sites in the
Astex Diverse cognate-docking benchmark of 85 com-
plexes [12]. Note that in order to obtain as many examples
as possible, no limit was set on crystal structure resolution
or other technical aspects of structure quality.
The resulting set contained 30,999 PDB structures,
corresponding to 63,699 liganded binding sites. These were
organized by annotated UniProt ID and sorted by the
number of ligands per target. The top 16 such targets each
contained more than 70 ligands, and 10 of these targets
form the benchmark data set summarized in Table 1. These
ten targets represent a diverse set of protein types: a ty-
rosine phosphatase (PTP1b), two aspartyl proteases
(BACE1 and HIV-PR), a mitogen-activated protein kinase
(MAPK14), a serine-threonine kinase (CDK2), a serine
protease (thrombin), a ligand-modulated transcription fac-
tor (PPARc), a metal-dependent dehydratase (CA-II), a
heat-shock protein (HSP90), and a transcriptase (HIV-RT).
All are either targets of existing drugs or have been actively
pursued as drug targets. Three of the 16 were eliminated on
the basis of redundancy with another target or target class
(P00760: trypsin, P00742: factor Xa, O14757: chk1).
Another three were eliminated because the proteins were
from non-human, non-pathogenic organisms. These three
were judged to be of limited pharmaceutical relevance
(P00489: glycogen phosphorylase [rabbit], P19491: gluta-
mate receptor 2 [rat], and P29476: nitric oxide synthase
[rat]). Additional details on preparation protocols can be
found below in Computational Procedures.
The total number of ligand binding sites was 1261.
Overall, 89 % of the structures had resolution of 2.5 A˚ or
better, and the poorest resolution structure was 3.3 A˚. Data
for each target was partitioned by sorting on the PDB de-
position dates, making use of the oldest 25 % (312 ligands)
for use as information to guide bindingmode predictions and
reserving the remaining 75 % (949 ligands) for testing
docking protocols. Table 1 breaks the data set down by tar-
get, sorted by binding site volume. HIV-PR had the largest
andmost flexible ligands, with the other pole being occupied
by HSP90a and CA-II. Overall, 18 % of test ligands had 3 or
fewer rotatable bonds, 38 % from 4 to 7, 24 % from 8 to 12,
16 % from 13 to 19, and 5 % had 20 or greater.
The eight largest binding sites are depicted in Figs. 3
and 4. Each is shown with white mesh enveloping the full
scope of the binding site as explored by the test ligands.
Within each target site, five ligands are shown, those ex-
amples belonging to the binding sites chosen as being
representative of each target’s early set (the choice process
is described below).
Table 1 Summary of target and ligand characteristics, sorted by binding site volume
Target UniProt N early Date cutoff N future Volume (A˚3) MW (mean ± SD) NRot (mean ± SD)
PTP1b P18031 17 15-Jan-03 52 3102 505 ± 151 10 ± 5
BACE1 P56817 34 4-Dec-07 103 2360 481 ± 154 10 ± 7
MAPK14 Q16539 30 12-Oct-07 92 2232 435 ± 87 7 ± 3
HIV-PR P0336[6/7/9] 42 a 127 1892 622 ± 121 16 ± 5
Thrombin P00734 37 26-Sep-01 114 1858 430 ± 97 9 ± 4
PPARc P37231 21 22-Aug-06 62 1443 414 ± 122 8 ± 4
CA-II P00918 42 21-Apr-05 128 1420 299 ± 81 6 ± 3
HSP90a P07900 32 28-Jun-07 98 1329 301 ± 111 4 ± 3
CDK2 P24941 42 26-Jun-03 127 1237 343 ± 78 5 ± 2
HIV-RT P04585 15 19-Jul-99 46 614 369 ± 79 5 ± 2
a HIV-PR was annotated in the PDB within three UniProt families, treated each with their own date cutoffs, respectively: 22-Dec-05, 11-Apr-97,
and 11-Jun-02
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The four largest sites had volumes spanning
2000–3000 A˚3. PTP1b is the largest, by far, with a char-
acteristic ligand binding mode that involves a salt-bridge
typically between a carboxylate on the ligands and Arg-221
on the protein (marked as 1 in Fig. 3). The site can
accommodate extremely large ligands, including some that
span the longest extents of the envelope depicted. BACE1
is an aspartyl protease, where the common recognition
motif of inhibitors includes interaction with the active-site
aspartic acid residues (2 in the figure). HIVPR, another
Fig. 3 The four binding sites with the largest volumes
Fig. 4 The protein binding sites with volume sizes ranked 5–8
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aspartyl protease, is analogously marked (3 in the figure).
MAPK14 has its hinge binding region marked (4).
In Fig. 4, thrombin has the S1 binding pocket marked
(1), with ligands typically containing basic moieties for
salt-bridging to an aspartic acid residue, but neutrally
charged S1 elements emerged over time in development of
thrombin inhibitors. PPARc has a complex active site, with
a site frequently occupied by a ligand carboxylate (2) and a
helix (3) around which the typically very flexible ligands
bend. The PPARc ligands in Fig. 4 all exhibit a canonical
binding mode, but a very different alternate mode was
discovered over time. CA-II ligands interact with an
essential zinc ion (marked 4), very often containing a
sulfonamide that is thought to interact in its anionic form
[36]. The active site opening is fairly wide, offering op-
portunities for many different protein-ligand interactions.
HSP90 is marked with a characteristic interaction to resi-
dues Asp-93 and Ser-52 (5).
For all ten targets, the overall volume that is explored by
the test ligands is much larger than that observed within the
structures used for docking. Even considering the full
complement of the ‘‘early quarter’’ of protein-ligand
complexes for each target, the scope and variety of inter-
actions observed later in time represent very challenging
problems for binding mode prediction. For this reason, an
effective strategy for choosing representative protein
structures from among those available at a particular time,
independent of any knowledge of the future ligands to be
predicted, is critical.
Systematic choice of representative protein
structures
Given a collection of protein structures, there will be re-
dundancy among many variants, and there will also be
outliers. In order to perform well with respect to docking
new ligands, structures must be chosen to be representative
of the important variants in the collection. The procedure
we have adopted computes all pairwise distances between
structures based on protein binding pocket similarity, using
the PSIM approach [33, 34]. Given these data, choosing a
specified number K is accomplished using K-means clus-
tering, with the exemplars for each cluster being those that,
on average, are closest to all cluster members (essentially
the cluster centers).
A mutual alignment is constructed using single-linkage
hierarchical agglomerative clustering. Figure 2 shows the
alignment tree along with the five chosen variants for
CDK2. Note that the five chosen representatives (the pro-
tein ensemble) come from different parts of the tree. With
the exception of 1H1P, all are clearly part of groups of
closely related protein variants (the values on the graph’s
edges are protein pocket similarity scores). The protein
alignment is done to maximize the surface concordance of
the protein variants according to the PSIM metric.
Exploitation of known substructural fragments
In Fig. 5, the core scaffold (2-anilino-pyrimidine) of the
ligand in question can, for example, be found in the ligand
of 1H01 (among several others). In this case, the common
substructural fragment offers an excellent guide as to the
correct primary alignment of the test ligand. Non-exhaus-
tive dynamic substructural matching of a test ligand to the
full set of previously known bound ligands is done in order
to identify well-positioned fragments. These fragments are
used to provide additional search focus on binding motifs
that are supported by experimental evidence.
For each molecule to be docked, a set of substructural
matches (containing at least four heavy atoms) are
Fig. 5 Dynamic substructure matching of a ligand to be docked to
ligands whose bound poses are known is used to provide additional
search focus on known binding motifs. Note that the ligand
conformations shown are from the respective crystal structures to
illustrate the relative alignments of known fragments to those present
in the subject ligand
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identified from the set of bound ligands. The search for
matching substructures is performed in a depth-first man-
ner, while keeping track of the largest yet-discovered
substructure and the total number of recurrence initiations.
The search is terminated either by exhaustion or when
more than 10,000 recurrence initiations have occurred
since the last discovery of a larger matching substructure
between the molecule to be docked and the known mole-
cule. Redundant matches are eliminated for each known
molecule. After identifying all such substructural matches
for all of the user-provided molecules, the GSIM 2D
similarity score [37] is computed between each substruc-
tural match and the whole ligand, with the top scoring
matches being retained (with a default maximum of 50
matches for docking a particular ligand).
The substructural matches are used in addition to the
standard alignment procedures within the Surflex-Dock
search algorithm [10, 38]. The additional computational
cost of this additional search focus is low, because the
substructure identification procedure is non-exhaustive and
computing a maximum of 50 additional alignments per
ligand conformation is computationally inexpensive. The
median docking times using a single computing core on a
standard desktop workstation circa-2013 were roughly
5 min per ligand for targets with typically sized ligands
(e.g. CDK2), but for targets with highly flexible ligands
(e.g. HIV-PR), times increased to 10–20 min per ligand.
Use of molecular similarity to influence pose ranking
The experimentally determined configuration of the 2XNB
ligand (tan sticks, lower left of Fig. 2) manifests a core
hinge-binding interaction common among many early
CDK2 inhibitors. Clues as to the likely positions and ori-
entations of the pendant groups may be found as well (e.g.
favorable positions for cations to make salt-bridges). Here,
the 3D similarity of each predicted ligand pose from
docking to the set of those previously known is computed.
These similarity values are re-cast as probabilities, and the
natural relationship between probabilities and energies is
exploited in order to provide a correction to the energetic
score for each pose. Using the new scores, pose families
are generated. In this example, the cluster of prediction
poses covers that derived from experiment, with the closest
being 0.5 A˚ RMSD.
Figure 6 shows a predicted pose for the 2XNB ligand
(A), along with a depiction of its surface shape and elec-
trostatic similarity to the bound pose of the ligand of 1FVV
(B). Green sticks indicate high shape similarity, and blue
and red sticks depict high similarity in polar characteristics
(positive and negative features, respectively). While both
compounds are aniline derivatives, it is the similarity of the
more structurally divergent parts of the molecules that
drive the high similarity.
We have previously introduced the idea of using pose
families of closely-related ligand configurations to repre-
sent the results of docking [38]. Rather than treating the
final predicted pool of n poses as individual and indepen-
dent predictions, pose families are constructed based on
RMSD, and they are ranked based on Boltzmann-derived
probability scores. A given score of x (between 0 and 1) for
a particular pose family means that it is expected for the
experimentally observed bound configurations of the ligand
in question to fall within that family with probability x.
Figure 7 shows the two top-scoring pose families for the
A
B
Fig. 6 Molecular similarity to bound ligands of different scaffold
types can help in pose-ranking
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ligand of 2XNB. Without adjustment based on prior
knowledge of other bound ligands, using only docking
scores, the bottom (incorrect) pose family received a
probability score of 0.57, with the top receiving a score of
0.31. The challenge is to make use of knowledge of prior
ligand binding modes in order to distinguish the correct
binding mode (A) from the incorrect mode (B).
The procedure we employ takes an idea from statistical
potentials, which derive energy functions from observed
distributions of molecular configurational properties
(typically distances). In the case of amino-acid residues,
the free-energy of interactions between residue types i and j
is given as follows [39]:





The notion is to determine the distribution of observed
configurations compared with a reference state. Con-
figurations that are common in the observed data relative to
the reference state lead to a high relative likelihood and
consequently a favorable negative energy. Here, we use
this idea to provide an energetic correction predicted
molecular poses, where those that appear to be more
‘‘native-like’’ are treated in an analogous fashion to amino-
acid distances that are frequently observed within ex-
perimental data. We must compute a relative likelihood
that a given pose for a ligand is native-like given infor-
mation about the experimentally determined poses of other
ligands.
Suppose we have a collection of docked poses for a
ligand, denoted L1...n, some of which are close to native and
some not. We can use a similar formulation to Eq. 1 by
expressing the similarities of these poses to native poses in
terms of probabilities. We have previously shown how to
transform the results of molecular similarity computations
into probability values by comparing the magnitude of a
similarity score for molecule A versus B to the distribution
of scores for A and B compared with a random background
set of molecules [40, 41]. In that work, given the maximal
similarity of A to B (in any energetically reasonable con-
formation of either molecule) the problem was to assign a
probability of observing a similarity value or that magni-
tude or higher. In the present case, we have a different
situation, in two respects. First, we have particular poses of
a ligand L1...n that fit within the active site of a particular
protein; as such, they represent a small fraction of the
configurational space available to the ligand. Second, we
have a set of native poses of multiple active-site bound
ligands, one each (denoted K1...m). We compute the mean
and standard deviation of the distribution of Surflex-Sim
3D pairwise molecular similarities between the predicted
poses L1...n and the known bound poses K1...m (denoted l
and r).
So, we have estimated l and r for the population of all
poses of L that fit within the active site, based on the results
of the docking procedure. For a particular pose Li, its av-
erage similarity to the set of bound poses is computed
(similarity function denoted by S). Within the population of
poses for L that fit within the active site, the average of
these m similarities should have a distribution with mean l
and with variance r2=m. We define a correction to the
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Equation 4 is simply the area under the right-hand side
(high similarity) of the expected distribution of average
similarity values to the known poses. A predicted ligand
pose that looks much less native-like than other predicted
poses would receive a low similarity score, resulting in a
value close to 1 from Eq. 4 and an energetic correction of
Fig. 7 The top scoring pose families for the 2XNB ligand for
knowledge-guided docking (a marked ‘‘G-’’) and unguided docking
(b marked ‘‘U-’’). The crystallographic pose (two alternates) are
shown in thick tan sticks with the docked pose families shown in
contrasting color
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close to zero. Conversely, a predicted ligand pose that
looks very native-like compared with other poses would
receive a low probability and a large, favorable energy
correction from Eq. 5. In practice, a lower bound of 1
106 is used for the probability scores to limit the max-
imum size of the score adjustment.
Recall from Fig. 7 that the two top-scoring pose families
for the ligand of 2XNB were incorrectly ranked, with the
bottom (incorrect) pose family receiving a probability score
of 0.57 and the top 0.31. After the similarity-based adjust-
ment of docking scores using similarity to known, bound
inhibitors, the probability scores changed to 0.0001 and 0.98,
respectively. The value of the docking score adjustment for
the singlemost native-like pose of the ligandwas?3.1 (units
of pKd). The labels ‘‘G-Fam-1’’ and ‘‘U-Fam-1’’ indicate
‘‘knowledge-guided protocol family number 1’’ and ‘‘un-
guided protocol family number 1’’ respectively. This label-
ing conventionwill be used throughout the figures to identify
protocols and pose family rank numbers.
Computational protocols
Automatic procedures were used for protein and ligand
preparation (including protonation and assignment of tau-
tomeric states), test ligand pose randomization, binding site
alignment within each target, and setup of all docking runs.
Manual inspection of protein-ligand complexes for clear
errors resulted in corrections for less than 5 % of struc-
tures. The full PINC benchmark along with the scripts used
to produce the primary results of this study are available at
www.jainlab.org.
Data set preparation
The pipeline for automated curation and alignment of the
ligand-bound protein variants was described in a previous
study that was focused on binding site comparison [34],
and the overall strategy and characteristics are described
above. Manual curation was required post facto to identify
and correct ligand structural errors (typically bond order
mistakes), and to identify cases where the automatic pro-
cedures yielded examples inappropriate for testing varia-
tions of docking procedures. Such cases included those
where a metal ion is generally not present in a binding site
(e.g. in thrombin and CDK2) but where one is required for
ligand binding (e.g. zinc-dependent thrombin inhibitors
and magnesium-dependent CDK2 ligands) and cases where
the ligand was occupying a non-overlapping site. No at-
tempt was made to ‘‘match’’ the test sites to the training
sites in terms of protein configuration, protonation or tau-
tomeric state, or ligand similarity or size. The only re-
quirement was that ligands for a site within a particular
target bound in roughly the same place (i.e. that the cen-
troid of any particular ligand was not too far from the
centroid of all of the ligands).
For each target, the collected curated structures (both
training and testing) were subjected to all-by-all protein
pocket alignment (using Surflex-Dock’s psim_align_all
command). The command produces pairwise alignments
(similarity scores and corresponding transformations)
along with (potentially multiple) single-linkage hierarchi-
cal protein-similarity trees, where the alignments within
each tree are from the ‘‘descendant’’ protein to it’s ‘‘par-
ent.’’ Using the PDB deposition dates, the earliest 25 % of
complexes were partitioned from the remaining complexes,
which were used for testing. Five exemplars for each target
were chosen from the early complex set using Surflex-
Dock’s psim_choose_k command.
Given the five identified cluster centers, the early com-
plexes in their mutual alignment, and the testing complexes
in the same mutual alignment, each target’s docking data
was derived. For each target, this consisted of the follow-
ing: protein[1-5].mol2 (protein active sites trimmed around
the bound ligand), ligand[1-5].mol2 (the bound ligands),
EarlyHints.mol2 (all ligands from the early complexes),
TestRef.mol2 (the test ligands in their bound poses), and
TestMols.mol2 (the test ligands as input to the docking
process). The test ligands were assigned random torsional
angles for all rotatable bonds, then they were minimized,
and their alignment parameters were assigned random
values. This procedure was employed in order to remove
bias and memory effects from the input to the docking
protocols. Preparation scripts were also produced to build
the input files for docking, including the ‘‘protomols’’ used
within the Surflex-Dock algorithm.
Every effort has been made to produce a clean bench-
mark, but the challenges in constructing large-scale sets
from the PDB should not be underestimated. The single
largest challenge is the variable quality of information
about bound ligands. For example, the ligand of 2XNB (see
Fig. 2) was incorrectly represented within the PDB as an
extremely high-energy tautomer of the correct structure
(the single-bond between the aniline nitrogen and phenyl
ring is swapped with the adjacent double-bond in the aro-
matic ring). We employ heuristic computational procedures
to identify and correct many such mistakes, but some are
detectable only by human inspection. Manual inspection
and correction affected less than 5 % of the complexes.
Docking protocols
Within the docking procedure itself, two variations were
tested, one using substructural hints (see Fig. 5) and one
without. The former was specified by adding the option -
lmatch EarlyHints.mol2 to the docking command
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gdock_list, and the latter omitted the option. Following the
docking procedure, two variations of pose-family gener-
ated were tested, one making use of bound ligand poses
(see Fig. 6) and one without. The former was specified by
adding the option -posehints EarlyHints.mol2 to the pose-
fam command, and the latter omitted the option. Additional
experiments to examine the effect of protein variant
choices were done by using alternate target input specifi-
cations, but all other aspects of the computations remained
the same.
The docking procedure employed was a variation of the
ensemble-docking protocol implemented within Surflex-
Dock and reported previously [38]. The previous ensemble
docking command of Surflex-Dock has been generalized
for this work in order to support multiple strategies for
controlling the optimization of ligand poses, but the scoring
function was unchanged. The generalized version makes
use of pre-searched conformations of ligands to be docked.
This procedure enumerates reasonable, diverse, low-energy
conformations (including flexible ring variations) of a
given input ligand (by default, up to 200 conformations are
retained). Ligand preparation for docking was made using
the search_library command of Surflex-Dock. Note that all
ligand preparation for docking was done beginning from
ligand coordinates with no ‘‘memory’’ of the crystallo-
graphic coordinates (see the description of the preparation
of TestMols.mol2 above).
The standard command employed for the docking runs
using substructural hints was: surflex-dock.exe-lmatch
EarlyHints.mol2-pgeom gdock_list Mols/pre-list Targets
loghints. The standard command for producing pose
families using bound ligand poses was: surflex-dock.exe-
posehints EarlyHints.mol2 posefam loghints. Docking was
performed using Surflex-Dock version 2.742.
Evaluation of results
The pose families resulting from docking under the dif-
ferent protocols were evaluated by computing, for each test
ligand, the minimum RMSD for each family to the refer-
ence pose of the ligand, correcting for internal symmetries.
In the case of HIVPR, C2-symmetry was also accounted
for because of the geometry of the active-site. The bulk of
analysis involves consideration of the cumulative his-
togram of RMS deviations on a per-target basis. The cu-
mulative histogram is simply a numerical integration over a
standard histogram which transforms the frequency count
(ordinate) for each binned value (abscissa) into a cumula-
tive proportion (range 0–1, ordinate) for each value
(abscissa).
In order to assess the degree of variation among protein
variants for each target, the global distribution of all
within-target protein similarity values was used to set a
threshold, below which protein variants were considered to
be novel. In an analogous fashion, binding modes for test
ligands were judged for novelty based on their maximal
similarity to previously known bound ligands (both in their
experimental poses). The threshold for ligand binding
mode novelty was also based on a global analysis for all
targets.
In some of the analyses, 2D molecular similarity was
employed to assess the degree to which a test ligand was
closely related to previously known ligands. The GSIM
method was employed in all such analyses [40]. Given two
molecules A and B as input, the method identifies all
subgraphs of molecule A up to depth 3 at each heavy atom.
For each subgraph, its existence is checked in molecule B.
The tally of matches is kept, weighted to favor subgraphs
rooted at heteroatoms. The computation is carried out bi-
directionally, and the result normalized to a scale of 0–1.
Results and discussion
The prediction task examined here parallels that frequently
seen by molecular modelers: given some new molecule that
is structurally different from those seen before, identify the
manner in which it binds the particular active site in
question. Questions about binding mode frequently occur
following verification of biological assay against a target of
interest following a high-throughput screen. They also arise
when new ligand structures are reported within the scien-
tific or patent literature. Understanding the geometric re-
lationship between new ligands and ones that have been
studied can be of great utility in shaping design decisions
during lead optimization. By partitioning our set of protein-
ligand complex data temporally, by target, we have tried to
mirror the interesting case: one where there is sufficient
uncertainty about the binding mode of a particular ligand
(or its effect on a binding pocket) that it is worth the time
and effort to make an experimental determination by X-ray
crystallography.
Table 2 summarizes the prediction results for each target
and overall. By combining substructural guidance during
docking and similarity-based guidance in ranking pose
families, we achieved a mean success rate for top-scoring
pose families of 62 %. Considering the top two pose
families, the overall success rate was 74 %. Figure 8 (left
plot) shows the cumulative histograms of success rates
aggregated for all targets under three protocols: (1) no
knowledge-based guidance; (2) guidance only from sub-
structural hints during docking; (3) and additional guidance
from knowledge of bound ligands for pose family ranking
(as with the results in Table 2). Each of the shifts in dis-
tribution of RMSD was statistically significant (p  0.001
by Kolmogorov-Smirnov).
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At right in Fig. 8, performance is shown for all pose
families to illustrate the effects of using protein ensembles.
The red and blue curves show the effect of substructural
guidance during docking, which is marginal at the
2.0 A˚ threshold, but significant overall. The green curve
shows the effect of using the individual protein exemplars
singly for all targets, giving the overall performance for all
targets and all protein exemplars. The improvement using
protein ensembles was highly significant compared with
using single protein variants. The per-target patterns of
performance using different single variants compared with
using the ensemble exhibited some diversity, and this will
be discussed below.
Analogous plots for individual targets (all except for
CA-II, which exhibited little relative novelty in the context
of the other nine targets) are shown in Figs. 9 (overall
docking performance) and 10 (effects of protein ensemble
use). In Fig. 9, the blue and magenta curves correspond to
the top scoring pose family and top two, respectively, with
the yellow highlight bar showing the success rate for a
threshold of 2.0 A˚. When using both types of knowledge-
based guidance, except for PPARc, typical success rates for
top-scoring pose family (the blue curves) ranged from 60 to
75 %. The gap between the red and green curves represents
the value of using substructural hints during the docking
process. The gap between the green and blue curves shows
the value of using similarity to known bound poses of li-
gands in addition to the substructural hints during docking.
Overall, as seen in Fig. 8, the value of substructural hints
was less (often substantially so) compared to similarity-
based information for pose family re-ranking.
The effects of using a protein ensemble versus using the
individual exemplars within the ensemble were more varied.
In all cases, it was possible to choose a particular protein
from among each set of five that would produce substantially
poorer performance than other variants or the ensemble
produced. In a few cases, fortunate choice of a particular
ensemble member yielded performance nearly as good as
seen from the ensemble (see the thrombin and HSP90 ex-
amples, in particular). In two cases (MAPK14 and BACE1),
performance using any single protein variant was substan-
tially worse than that observed using the ensemble.
The three most challenging targets from our previous
study (CDK2, thrombin, and MAPK14 [31]) yielded ex-
cellent performance in the current study, with mean per-
formance of 71 % for top-scoring pose family and 80 % for
Table 2 Summary of results in terms of success percentages at an
RMSD threshold of 2.0 A˚ for the top pose family, top 2, 5, and 10
Target N test Top family Top 2 Top 5 Top 10
PTP1b 52 50 67 77 83
BACE1 103 57 71 85 88
MAPK14 92 71 79 89 93
HIV-PR 127 55 69 75 80
Thrombin 114 68 76 81 83
PPARc 62 31 34 39 45
CA-II 128 63 77 88 94
HSP90a 57 57 72 91 91
CDK2 127 75 85 93 96
HIV-RT 46 63 78 87 91
Overall 949 62 74 83 87
Fig. 8 Overall performance of Surflex-Dock under different docking protocols (left) and considering the effect of using a protein ensemble
(right) compared with a single protein variant for each target (aggregated over five different selections each)
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the top two. In this study, the most challenging targets were
PPARc, PTP1b, and HIV-PR. These shared in common the
highest proportion of test ligands whose structures were not
only very different by 2D similarity to previously known
ligands, but they were also very different in terms of their
maximal 3D similarity (in their bound pose) to previous
ligands. Other aspects such as ligand size/flexibility and
binding site volume were less important.
In what follows, performance on each target will be dis-
cussed in some detail, with particular attention paid whether
Fig. 9 Overall docking performance under different docking protocols for nine targets. The key curves are blue (top scoring pose family using
the knowledge-guided protocol), magenta (top two pose families), and red (top pose family in the unguided protocol)
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the knowledge-utilization strategies had different impact on
different targets. The order in which the discussion is orga-
nized is from best to worst performance for top-scoring pose
family (using both types of structural guidance): CDK2,
MAPK14, Thrombin, HIV-RT, CA-II, BACE1, HSP90a,
HIV-PR, PTP1b, and PPARc. This corresponds to the order
seen in Figs. 9 and 10. Following that, the effects of our
protein selection procedure will be discussed.
Fig. 10 The effects of using single protein exemplars versus an
ensemble of five for nine targets. The key comparisons are between
the red curve (protein ensemble with no substructural guidance during
docking), blue curve (adding substructural guidance), and the
remaining curves (each from a single protein variant from the
ensemble, using no substructural guidance)
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CDK2
CDK2 was used as an example throughout the description
of the methodology, as it represents a typical case in terms
of performance within the overall benchmark. As seen in
Fig. 9, the use of substructural information during docking
produced a mild performance improvement (roughly 4 %
points), but the use of similarity-based knowledge of prior
known ligand binding modes produced a large improve-
ment (roughly 17 points).
The reasons are two-fold. First, except for a few target
cases, the search algorithms within the Surflex-Dock opti-
mization procedure are generally adequate for identifying
some close-to-correct poses within the set of 100 produced,
even without using any information about previously
identified binding motifs (the red curves in Fig. 10). Se-
cond, the difference in energy between native-like solu-
tions (e.g. Fig. 7a) and incorrect ones (Fig. 7b) is small,
often (as in this case) less than 1 kcal/mol. So the problem,
generally speaking, is not one of discovering a good so-
lution, but ranking it as such.
These observations paralleled our previous study, using
a much smaller data set from Sutherland et al. [29]. In that
work, CDK2 was among eight different targets, with 211
ligands used for testing overall. Pose ranking was the key
problem, with less than half of the cases in which a correct
pose was produced being correctly identified as such. In the
previous work, protein pocket adaptation (Cartesian-space
all-atom optimization) was used to influence pose family
rankings. In the most difficult cases, of which CDK2 was
one, such optimization was able to improve success rates
for top-ranked pose family by a few percentage points.
However, the case in which two variant methods for pocket
adaptation resulted in agreement between the top-ranked
pose families, there was a very substantial improvement in
success rate.
In the present work, rather than identifying cases in
which alternate methods agree on a particular ligand
(which may happen infrequently), the current approach
looks for agreement, measured by similarity, to the known
configurations of bound ligands whose structure was de-
termined at an earlier time point. For CDK2, this resulted
in a success rate of 75 % for top-ranked pose family and
over 85 % for the top two. Failures to identify any correct
solutions happened less than 5 % of the time.
The behavior of the CDK2 case with respect to protein
variant choice was also typical (see Fig. 10, top left). Two
particular variants, when used alone (the green and teal
curves), yielded poor performance. That is, even when
selecting from among the five variants, each of which was
itself the center of a cluster of variants, it was possible to
obtain one that could not be used to identify reasonable
poses for many ligands. Three other variants (the magenta,
brown, and dark blue curves) performed nearly as well as
the ensemble (red curve), except at lower thresholds of
RMSD, where a significant advantage for the ensemble
approach emerged. Importantly, it is not clear that one can
know whether a single variant can be generally successful
nor if that is the case which one will perform well. So,
making use of the ensemble is an effective strategy. In
some cases (discussed more below), it is essential.
One additional point is illustrated in Fig. 11. In the case
of the 2XNB complex, the deposited structure contained
two alternative poses for the ligand, the first of which was
used for the deviation calculations. The bottom of Fig. 11
shows the density corresponding to the ligand (red mesh)
along with the two modeled alternative poses, which ap-
pear to represent a good explanation of the observed den-
sity. The top of the figure shows the full set of poses for the
top-ranked pose family, along with an imputed density
surface (in transparent blue), contoured to provide a com-
parison with the experimental density. It seems probable
that numerous solutions exist which simultaneously respect
the internal energetics of the ligand, the observed density,
Fig. 11 The experimental electron density (red mesh) for the 2XNB
ligand is shown along with that computed for the entire top-scoring
pose family ensemble (thin cyan sticks with blue transparent surface,
a) and for the two alternate poses modeled in the crystallographic
experiment (thick tan sticks with gray transparent surface, b)
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and sensible interactions with the protein. While the posi-
tional variation seen at the left-hand-side of the ligand in
the full predicted pose family may extend beyond what is
supportable by experiment, more variation than is repre-
sented in the modeled structure may exist. We believe that
the perspectives of both the structural biologist and the
molecular modeler can benefit from broader consideration
of pose variants than has been historically done.
MAPK14
Overall performance on MAPK14 was very similar to that
seen for CDK2, with the exception that the benefit from
making use of substructural knowledge was slightly higher.
There was a roughly 9-point difference in success rates a
the 2.0 A˚ threshold when comparing the red and green
cumulative histograms of Fig. 9. The top scoring pose
family using both types of knowledge-based guidance was
70 %, and the top two pose families yielded 80 % correct.
Note that, as with CDK2, MAPK14 was among the three
most challenging targets in our previous work, but the
combination of knowledge-guidance from substructural
hints and similarity-based pose family re-ranking made it
the second-best in this work.
As with CDK2, there was significant performance var-
iation among the five chosen protein pocket variants, when
used singly (see Fig. 10, top middle plot). However, in
sharp contrast, the very best of these performed 26 %
points worse than the ensemble. In this case, joint use of
the five proteins was crucial to uncovering correct solutions
for many ligands. The only other target where this pattern
emerged was BACE1. These two cases were used for a
systematic test of different strategies for choosing protein
ensembles, the results of which will be discussed after the
individual protein targets.
Thrombin
Thrombin was the third of the three targets shared with our
previous cross-docking study, and as with the previous two
discussed, was one of the most challenging. In that work,
top-scoring pose family success was roughly 50 %, with
the top two pose families achieving roughly 60 %. Here,
the comparable numbers were 68 and 76 %, with the dif-
ference being essentially entirely attributable to the use of
similarity-based re-ranking of poses. Figure 12 shows the
results of docking for the test ligand from PDB structure
1ZGV, an example of a thrombin inhibitor with a non-basic
S1 binding pocket element. The result obtained from an
agnostic docking protocol yielded an RMSD of
3.7 A˚ (top), getting the placement of the S1-pocket ele-
ment correct, but flipping the remainder of the molecule
out of the correct pose. The unguided protocol contained an
excellent solution (0.7 A˚), but the docking score for that
solution did not result in the top-scoring pose family. Use
of substructural guidance produced more numerous and
better solutions, which, with the inclusion of similarity-
based re-ranking, yielded a solution with just 0.6 A˚ de-
viation (bottom of Fig. 12). This case represented a
thrombin inhibitor of limited flexibility (just 6 rotatable
bonds), which presented little challenge with respect to
search adequacy but was difficult in terms of the precise
ranking among the poses produced.
A more challenging example, with 11 rotatable bonds, is
shown in Fig. 13. This structure was deposited in the PDB
in April 2011, nearly ten years after the most recent
structures from the ‘‘known’’ pool. The top-scoring pose
family in the agnostic protocol contained a single pose,
which was flipped completely around the central proline,
resulting in a deviation of 8.5 A˚. Under the guided proto-
col, the top-scoring family (bottom left), achieved a degree
of congruence with the experimental solution, correctly
placing the sulfonamide substituent and obtaining grossly
correct positions for the proline linker and the chloro-
benzylamine (2.3 A˚ RMSD, 51 % probability score). The
Fig. 12 For thrombin, comparison between docking without knowl-
edge-based guidance (top right, pink) and with guidance (bottom,
cyan) for the ligand of 1ZGV, a triazolo-pyrimidine with a non-basic
S1 binding element, (top left in 2D and thick tan sticks in its
experimental pose)
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second pose family (46 % probability) was correct, devi-
ating 0.5 A˚ from the experimental pose.
The nominal docking scores of the various solutions
represented in Fig. 13 were within 1.0 kcal/mol of one-
another. Cases such as this, with flexible peptide-like li-
gands having low ligand-efficiency, are among the most
challenging in pose prediction. Approaches that seek to
disambiguate such pose variants using purely energetic
estimation approaches face a high bar. Note that the correct
position of the primary amine is away from the aspartic
acid residue within the S1 pocket of thrombin, instead
being apparently stabilized through intramolecular con-
tacts. Note also that the early complexes used to inform the
docking and pose-ranking protocol were dominated by
basic groups at the S1 position, with no examples of
chloro-phenyl or similar groups. The binding motif seen in
the linker from the S1 binding element (including the
sulfonamide) to the hydrophobic substituent was of use in
identifying the correct configuration.
HIV-RT
The HIV-RT ligands were bound in the non-nucleoside
binding site, which was the smallest site, by far, among the
ten targets studied (the next larger site of CDK2 was
slightly more than twice the volume). This, coupled with
limited ligand flexibility (an average of 5 rotatable bonds),
mooted the issue of search adequacy. No improvement was
observed using substructural hints during docking (see Fig.
9, left side, middle plot). In fact, over 95 % of test ligands
yielded a predicted pose with deviation less than
1.5 A˚ from experimental when considering the full set of
pose families produced (see Fig. 10). As was typical, par-
ticular choices of protein variant could yield poor results.
However, in this case, there was a single pocket variant
(protein 4) that performed indistinguishably from the
ensemble. HIV-RT was the only example where this was
clearly the case.
Despite the small volume, pose ranking for the small,
hydrophobic ligands was a challenge. Top-scoring pose
family performance was 63 %, with performance improv-
ing to 78 % when considering the top two families. Even
when considering the top ten families, performance was
91 %, still less than the 98 % success attainable (all but 1
of the 46 test ligands) when considering all pose families
that were generated.
Figure 14 shows the pocket volume along with docking
results that illustrate the challenge within this small pocket.
The top-scoring pose family (bottom left, cyan) deviated by
4.0 A˚ from experimental. The top-scoring family from the
unguided protocol was worse still (not shown). Clearly, the
second-ranked pose family (pink) matches the experimen-
tal pose better (0.5 A˚ RMSD), but the nominally large
difference in deviation between the two alternative stems
from two reasonable ‘‘flips.’’ The pyrimidine-dione is
flipped in the top-ranked configuration (‘‘G-Fam-1’’),
placing the N-ethyl at right, but the core scaffold is nearly
symmetric. The methyl and nitrile substituents are also
reversed, again not unreasonably. This is a case where
nominal RMSD gives an incomplete picture of how in-
formative a geometric prediction may be.
BACE1
Apart from being a more challenging case, BACE1 ex-
hibited the same overall pattern as MAPK14 in terms of the
performance benefits of knowledge-based guidance and
sensitivity to use of pocket variants compared with the full
ensemble. Substructural guidance during docking provided
a roughly 12-point improvement in performance (Fig. 9),
and similarity-based re-ranking produced roughly 17 points
on top of that, resulting in top-scoring pose family per-
formance of 57 %. Performance improved to 71 and 85 %
when considering the top two and five pose families, re-
spectively. The ensemble approach produced a more than
25-point improvement over the next best single protein
Fig. 13 Comparison between without knowledge-based guidance
(top) and with guidance (bottom) for the thrombin ligand within
3RML, showing the top two pose families in the guided case
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variant (Fig. 10). The effect of protein variant selection
strategy for BACE1 will be discussed below.
Note that BACE1 had the second-most flexible set of
test ligands (next to HIV-PR), with mean flexibility of 10
rotatable bonds (7). It was also the second largest site by
volume (next to PTP1b), with the site enveloping 2360 A˚3.
BACE1 is generally considered to be a challenging target,
in part because of the size and flexibility considerations, so
the pose-prediction performance we observed was striking.
Here, top-ranked pose family performance on diverse and
highly flexible ligands in a temporally segregated cross-
docking test matched that observed on challenging cognate
docking benchmarks [13, 14, 23] for multiple docking
methods (including methods such as Glide, ICM, GOLD,
and Surflex-Dock).
HSP90
The pattern of performance improvements for HSP90 most
closely paralleled that of CDK2, albeit at lower levels of
overall success. Substructural guidance during docking
provided a roughly 10-point improvement in performance
(Fig. 9), and similarity-based re-ranking produced roughly
13 points on top of that, resulting in top-scoring pose
family performance of 57 %. Performance improved to 72
and 91 % when considering the top two and five pose
families, respectively. The ensemble approach produced a
5-point improvement over the best single protein variant
(Fig. 10), and it was roughly 30 points better than the worst
variant.
HIV-PR
HIV-PR was, by a significant margin, the target with the
most flexible ligands (an average of 16 5 rotatable
bonds). That fact, coupled with an active site volume of
nearly 2000 A˚3, and a reasonably flexible protein, created
an a priori expectation of high difficulty. It was atypical in
that it was the only target for which substructural guidance
during the docking process yielded a larger improvement
(15 points) than similarity-based re-ranking (10 additional
points). This was likely due to the extreme flexibility of the
test ligands. Top-scoring pose family performance was
55 %, increasing to 69 % for two, and 75 % for top five.
The value of substructural hints is clearly seen in Fig. 10
(bottom left plot), where the difference between the red and
blue curves is only the use of substructural guidance. At the
2.0 A˚ threshold, such guidance yields a six-point advan-
tage (for an overall success rate for all pose families of
84 %). At the 1.5 A˚ threshold, the improvement was 20
points; clearly a very significant impact. Similar to BACE1
and MAPK14, but to a lesser degree, the use of a protein
ensemble produced better results than any single protein
variant.
Figure 15 shows a typical peptide-like inhibitor (the li-
gand of 1ZSR), having over 20 rotatable bonds. Two views
are shown of the top-scoring knowledge-guided pose
family, with the crystallographic pose shown in tan and
with a transparent surface. The RMSD of the closest pose
within the family was 0.8 A˚, and as the inhibitor meets
solvent (bottom left and front right in the figure) it exhibits
a greater degree of mobility in the docking result. We
believe that this picture of a binding-mode prediction is
more informative, and likely more accurate, than one
where a single pose is displayed.
Especially given the demanding characteristics of HIV-
PR, we view the performance of the knowledge-guided
protocol as being a success. More broadly, to summarize
thus far, performance using the knowledge-guided protocol
for all but two of the ten targets reported here (PTP1b and
PPARc, discussed below) met or exceeded 55 % for top-
ranked pose family and all but one (PPARc) met or ex-
ceeded 67 % for the top two. Except for perhaps two tar-
gets, the level of performance seen here for cross-docking
Fig. 14 The HIV-RT pocket volume (top) is shown along with
docking results for the ligand of 3LAL: tan sticks for the experimental
pose, cyan for the top-scoring pose family with knowledge-based
guidance, and pink for the second-ranked family
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matches that of challenging cognate docking benchmarks.
It significantly exceeds that previously reported on sub-
stantial cross-docking benchmarks such as those described
in the Introduction, where success rates of 20–30 % were
common in cross-docking with single protein variants [28–
31]. Note also that this is the only temporally segregated
benchmark of which we are aware, and it is also one of the
largest and most diverse in terms of both target types and
ligand structural variety.
PTP1b
PTP1b had the largest active site (over 3000 A˚3), and its
ligands were quite flexible (an average of 10 5 rotatable
bonds). The unusual aspect of performance for this target
was that, at the 2.0 A˚ threshold, no real improvement re-
sulted from use of either method for making use of prior
knowledge, at least for top-scoring pose family. At larger
deviations, there was a clear benefit for using substructural
guidance (see Fig. 9), but not for similarity-based re-
ranking. PTP1b also had the largest increase in success in
moving from a single pose family to two (17 % points).
Figure 16 illustrates the challenge of this binding site with
an example of the improvement seen between the top and
next best scoring pose family under the guided protocol.
The top scoring pose family, despite having placed the
buried substituent correctly, places the rigid ‘‘arm’’ of the
inhibitor in an incorrect position along the surface of the
protein (7.9 A˚ RMSD). The second-ranked pose family
(0.5 A˚ RMSD) was correct. The nature of binding for large
inhibitors in this class is mainly on the protein surface,
where much less physical constraint exists to constrain
potential docking solutions.
PPARc
PPARc was an outlier in terms of performance under all
circumstances: with and without knowledge-based guid-
ance and using any number of top-scoring pose families.
For the other nine targets, using the knowledge-guided
protocol, the success rate at the 2.0 A˚ threshold was 0:62
0:08 for the top-scoring pose family. For the top two, it was
0:75 0:06, and for the top five, it was 0:85 0:06. Per-
formance for PPARc was, respectively, 31, 34, and 39 %
under the same docking protocol, representing decreases in
performance of 4r or greater.
The active site of PPARc was of moderate volume
(1400 A˚3) and the ligands were of moderate flexibility (an
average of 8 4 rotatable bonds) for this set of targets. The
reasons for the difficulty appear to stem from two primary
drivers: (1) diversity in protein active site configurations
when bound to the test ligands; and (2) the fraction of novel
binding modes of test ligands compared with training
ligands.
For PPARc, protein binding site diversity was the
highest among all proteins. We computed the maximal
binding pocket similarities for each cognate pocket for
each test ligand against the pockets for all ligands within
the known early pool. We assessed the fraction of such
similarities that fell below a threshold set based upon a
Fig. 15 HIV-PR (magenta), shown in top view (left) and side view (right), with the top-scoring predicted pose family for the ligand of 1ZSR
(cyan with experimental pose in tan)
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global analysis of computations for all proteins (see
Methods), calling those sites with lower similarity novel.
For PPARc, the fraction of novel protein active sites was
49%. Interestingly, the two targets that benefited the most
from making use of a protein ensemble (MAPK14 and
BACE1) also had high novelty fractions (33 and 18 %
respectively). Among the remaining targets, active site
novelty fractions were all below 10 %, except for HIV-RT
(22 %) whose limited volume appears to ameliorate that
effect.
To assess novelty with respect to test ligand binding
mode, we performed a similar computation using 3D
similarity of the bound configurations of test ligands
compared with those of the known early pool. For each test
ligand, the maximum similarity to the knowns was com-
puted. Novel binding modes accounted for fully 50 % of
the ligands for PPARc. This appears to explain the relative
challenge of PTP1b as well, with 40 % of test ligands
exhibiting novel binding modes. The remaining targets
exhibited novel binding modes less than 10 % of the time,
except for HIV-PR (28 %) which was also a relatively
challenging target.
To put this issue of binding-mode novelty in perspec-
tive, recall Fig. 3. The marked locations ‘‘2’’ and ‘‘3’’
correspond to those marked in Fig. 3: (1) the canonical
binding location for acids; and (2) helix 12, the canonical
helix around which many ligands are known to bind [42].
Location 2 is surrounded by four donor protons (two from
histidine residues, one from serine, and one from tyrosine).
Figure 17 shows 11 canonical ligands (tan) from within the
early pool of 21 complexes that contained carboxylates in
favorable contact with this part of the protein. Also shown
are the 9 worst failures (cyan, based on best RMSD among
the top ten pose families). All of the latter placed car-
boxylates in a completely different place than that seen in
the canonical binding mode. In addition, a critical arginine
residue moves several Angstroms in order to complement
the binding mode seen for these difficult test ligands.
The extreme difficulty of this target was well
documented in a structural sense by Itoh et al. [42], where
hydroxyoctadecadienoic acid variants were shown to be
capable of binding in three divergent modes to PPARc.
One mode was in the canonical position, another in the
alternative mode that was common among the docking
failures, and a third in which a second ligand could bind at
the same time as one binding in the canonical mode (where
there was also a critical contact made between the ligands).
The PPARc case represents a true limitation for the
methods described here. Binding modes that are com-
pletely unlike those seen earlier will not be recovered
through use knowledge from previous ligands, either in
terms of substructural matching for configurational search
or similarity-based pose re-ranking. Further, careful auto-
mated choice of protein pocket variants from among a set
that does not contain a crucial rearrangement cannot help
to identify novel binding modes as are seen with this target.
Effect of protein variant selection
As seen in Fig. 10, selection of protein variants matters in
all cases, at least to the extent that a poor choice of a single
variant could lead to significantly worse results than the
choice of an optimal variant. This was also true for CA-II
(whose plot is not shown), especially at more stringent
levels of RMS deviation. In all cases, performance of the
ensemble (red curves) was much better than the worst
single variant, and in no case was the ensemble worse than
the best of the single variants. In two cases, MAPK14 and
BACE1, the ensemble was more than 25 points better than
that seen with the best single protein variant. This was, in
part, explained by the analysis of protein pocket novelty,
with these two cases showing a relatively high fraction of
novel pocket variations among the test complexes.
In order to assess the degree to which the protein variant
selection strategywas successful, two additionalmethods for
Fig. 16 PTP1b (pink) is shown with the ligand of 1Q6S (tan sticks),
the relevant known molecules sharing the difuoromethylphosphate
(green), and the top two predicted pose families (cyan and light
magenta)
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selecting five variants were tried for MAPK14 and BACE1.
The first was a maximally diverse selection strategy. Recall
that the strategy described earlier made use of K-means
clustering (with K of 5) along with selection of a particular
variant for each cluster whose average similarity to the other
members was highest. For the maximally diverse choice, the
set of 5 proteins that were maximally dissimilar to one an-
other were chosen (using a greedy algorithm beginning with
the single protein pocket most dissimilar from all others).
The second was a purely random strategy, in which five
different sets of five were randomly chosen.
Performance was assessed using the protocol without
any knowledge guidance when considering all protein
families generated from docking. For the K-means strategy
used throughout the paper, the success rates were 95 % for
MAPK14 and 87 % for BACE1. The ‘‘diverse’’ strategy
success rates of 66 and 82 %, respectively. For MAPK14,
the drop of 29 points was highly statistically significant
(p \106 by exact binomial). For BACE1, the drop of 5
points was just significant at the p = 0.05 level.
Using random selections, the average performance for
MAPK14 was 82% 14. Two of the five random selec-
tions performed as well as the K-means strategy (success
rates of 96 and 95 %), but three were significantly worse.
For BACE1, the average performance of the random se-
lections was 85% 2, matching that of the K-means
approach.
The K-means approach was at least as good as the best
of any alternative selection method, and it was clearly
superior to the ‘‘diverse’’ approach. The latter essentially
identifies outliers in protein pocket conformational space,
which probably do not represent the bulk of relevant con-
figurations for predicting the binding modes of new
ligands. Perhaps surprisingly, choosing random sets of 5
proteins each was a better approach than choosing
maximally different variants. In fact, for MAPK14, a for-
tunate choice of variants was as good as the careful
K-means approach in 2/5 replications. For BACE1, the
random approach never performed better than the K-means
approach, but it did not perform worse either. Overall, the
evidence suggests that making use of the K-means ap-
proach will result in the best performance, but testing such
strategies on additional targets appears warranted.
Conclusions
We have presented a new benchmarking data set for
assessing pose prediction using molecular docking called
PINC. The benchmark is focused on targets of pharma-
ceutical interest (ten total), where, for each target there is
an average of 95 ligands for testing (minimum of 46 and
maximum of 128). The test ligands were partitioned from
the training ligands temporally, with the earliest 25 % of
complexes deposited in the PDB being used as information
for use in making predictions on the remaining 75 %. This
was done for two reasons. First, it is likely that new
complexes are sought in cases where uncertainty exists as
to either the binding mode of a ligand or its effect on the
protein conformation. Second, it has been well established
that random partitioning has significant liabilities in
assessing the performance of predictive modeling for drug
design, because ligands are the products of human inven-
tion, with their structures often reflecting their ancestry [24,
37, 40, 43, 44]. So, making use of a ‘‘future’’ ligand in
order to predict the binding mode of a ‘‘past’’ one can often
embed the correct answer within the prediction task.
No effort was made to adjust the proteins used for
docking to suit the test ligands (either by selection or by
modification). Also, none was made to adjust test ligands
protonation or tautomeric state to match that of the proteins
used for docking (the test ligands were prepared with ref-
erence to their cognate proteins only). Last, no quality
parameters were used to limit the set of complexes that
formed the benchmark. Altogether, we believe the PINC
set to be the most relevant to the real-world problem of
structure-based pose prediction for small-molecule ligands
that exists.
We have presented two algorithmic enhancements to
Surflex-Dock, both allowing for exploitation of knowledge
of ligands whose binding mode had been previously de-
termined. The first, used during docking, automatically
identifies relevant matching subfragments between a sub-
ject ligand and known ones in order to focus additional
search on binding modes that have been seen previously.
The benefit of this method was typically 5–10 % points in
Fig. 17 Canonical early bound ligands of PPARc with a shared
binding mode (tan), along with the nine worst test cases (cyan), all
exhibiting a completely different binding mode for organic acids
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terms of improvement to top-scoring solutions at the
2.0 A˚ RMSD success threshold, but it was larger than that
for targets with particularly flexible ligands.
The second enhancement made use of an idea from sta-
tistical physics, where the degree to which a predicted pose
looked ‘‘native-like’’ was used in order to adjust its docking
score. A pose whose 3D similarity was unusually high to
those of known ligands in their experimentally determined
binding modes is quantitatively adjusted in energy based on
the estimated ratio of native-like to non-native probability.
This similarity-based re-ranking of poses yielded 10–20
points of improvement in success rates.
We also made used of a careful strategy to choose
among available protein variants using protein binding
pocket similarity [27, 33, 34, 45]. The strategically chosen
ensembles always performed as well as the best of all al-
ternative selection strategies, occasionally providing as
much as 25-point improvements over the best single pro-
tein variants and always providing substantial benefits over
the worst single variants.
All targets showed similar patterns of performance
benefits, with ensemble docking using five automatically
chosen protein variants, coupled with use of both types of
knowledge-based guidance for pose prediction producing
the best results. For nine targets (all but PPARc), perfor-
mance for this very challenging cross-docking problem
matched that seen for difficult cognate docking bench-
marks. In particular, the success rate at the 2.0 A˚ threshold
was 0:62 0:08 for the top-scoring pose family. For the
top two, it was 0:75 0:06, and for the top five, it was
0:85 0:06. We believe that, in cases where there is
binding mode uncertainty, manual visualization of a
handful of possible solutions is something that most
modelers will be willing to contemplate.
Clearly, there are many different strategies that could be
explored to achieve performance benefits such as those we
present here. In particular, choice of protein variant on a
per-ligand basis, as opposed to the ligand-independent
approach we have used, could be useful. Certainly, it has
been established in earlier cross-docking studies that in
cases where the ligand to be docked is highly similar to the
cognate ligand of a particular crystal structure, the chances
of successful pose predictions from docking increase [30].
In this benchmark, the fraction of cases where any of the
known structures contain a ligand that is highly similar to
one to be docked is relatively low, and it is the lowest for
the most challenging targets. Likewise, there are many
ways in which one can combine ligand similarity ap-
proaches with protein structural data. It is our hope that the
public availability of this benchmark will help to both
develop and evaluate such methods.
As discussed earlier, the performance reported here rep-
resents a significant improvement in a numerical sense over
previous cross-docking studies (even those constructed with
less challenging intentions). The importance of this im-
provement depends, to some degree, on how docking is used
in practice. We have not addressed the virtual screening
application of the methods described here; that will be
something addressed in future work. The use-case consid-
ered here, prediction of bioactive poses, is relevant in at least
two ways: (1) hypothesis generation for lead optimization;
and (2) as a starting point for binding affinity prediction.
Often, docking is used as an informal adjunct to lead
optimization, in which consideration of the likely binding
mode of a ligand within an active site informs ideas about
new molecules. Based on the temporal construction of the
benchmark, it is likely that binding modes were in question
for many of the cases examined here. We obtained predic-
tion of correct binding modes within the top two solutions
75 % of the time for all but one of ten targets. Experienced
modelers working on familiar proteins could achieve some
of the benefits of the automated methods presented. We still
believe that the lead optimization scenario is onewhere there
is likely to be a practical impact for what we have reported
here. When a new series is identified, either through
screening or through public disclosure in the literature, rapid
exploitation of the information is clearly valuable. The
methods presented here make it possible to systematically
exploit large quantities of pre-existing biophysical data.
Another related, but subtly different, use of docking is to
build support for a modeler’s notion of how a ligand may
bind. In such cases, direct ‘‘steering’’ of the docking
method is used to decide whether any pose exists for the
ligand that appears compatible with the hypothesis and
with available structural data. The methods presented here
offer an agnostic means to see if the modeler’s hy-
pothesized binding mode is independently reproducible
within a highly-ranked pose family. When confirmation
exists, it should provide confidence in the hypothesized
binding mode. However, the methods do not directly sup-
port such active steering for hypothesis verification. The
methods are designed for automated use.
Perhaps more important, though, is that computational
approaches for predicting binding affinity increasingly are
dependent on close-to-correct relative (or absolute) binding
configurations in order to produce the most accurate re-
sults. We have recently developed a structure-based means
to influence the construction of physical binding site
models for predicting ligand affinity [27]. In that approach,
docking is used to help construct hypotheses for initial
ligand alignments in order to bias model induction toward
solutions that are closer to biological reality, and models
constructed in such a manner are able to make accurate
affinity predictions on a broad variety of new ligands.
Methods utilizing molecular dynamics, such as MM/GBSA
and MM/PBSA, require that accurate binding modes for all
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ligands be known [46–48], so the methods reported here
could be utilized in such protocols as well.
Another observation through the course of this study has
been that ligand binding modes are, nearly always, repre-
sentable by quite large sets of closely-related poses. We
believe that the picture that is promoted by looking at
protein-ligand complexes as single, static configurations is
inaccurate and that it limits creativity in thoughts about
molecular design. We hope to develop methods to help
identify ligand variations that better model the experimental
data in X-ray crystallography. We also plan to make use of
the concept of pose families and information fusion using
probabilistic methods to improve both the quality and in-
terpretability of 3D-QSAR methods.
The work presented here represents the first general-
ization of our ongoing work using such techniques for
predicting polypharmacology [40, 41, 49]. We believe that
hybrid approaches that combine information from docking
and scoring, ligand similarity, and protein pocket similarity
will frequently show synergistic performance improve-
ments for lead discovery and for predictions of binding
mode, affinity, and off-target biological effects.
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